LabCorp Announces Definitive Agreement to Acquire US Pathology Labs, Inc.

BURLINGTON, N.C., Dec. 14 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) and US Pathology Labs, Inc. (US LABS), a provider of anatomic pathology and oncology testing services with a focus on the outpatient market, today announced that they have

LabCorp to Present at the Merrill Lynch Health Services Conference

BURLINGTON, N.C., Nov. 29 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the Merrill Lynch Health Services Conference in New York, NY on November

LabCorp & Allscripts Expand Relationship to Provide Chart-Based Lab Order Entry and Results Solution

FirstChart(TM) Allows Clients to Customize Connectivity Technology to Their Practices BURLINGTON, N.C., Nov. 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the availability of an innovative new chart-based laboratory order entry

LabCorp(R) Scheduled to Present at the Credit Suisse/First Boston Health Care Conference

BURLINGTON, N.C., Nov. 16 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the Credit Suisse First Boston Health Care Conference in Phoenix, AZ on

LabCorp Added to S&P 500 Index

BURLINGTON, N.C., Nov. 3 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Standard & Poor's (S&P) added the company to the S&P 500 Index as of the close of trading on October 29, 2004.

Laboratory Corporation of America(R) Announces 2004 Third Quarter Results

EPS Increases 13.8 Percent to $0.66; Company Announces New Share Repurchase Program BURLINGTON, N.C., Oct 21, 2004 (PRNewswire-FirstCall via COMTEX) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) , the clinical laboratory industry's scientific leader, today announced financial

LabCorp(R) Scheduled to Present at the UBS Global Life Sciences Conference

BURLINGTON, N.C., Sept. 24 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the UBS Global Life Sciences Conference in New York, NY on

LabCorp(R) Scheduled to Present at the Banc of America Securities Annual Investment Conference

BURLINGTON, N.C., Sept. 17 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the Banc of America Securities Investment Conference in San

LabCorp(R) Announces Results of its Offer to Purchase Zero-Coupon Subordinated Notes Due 2021

BURLINGTON, N.C., Sept. 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that no holders of its zero coupon-subordinated notes elected to exercise their option to redeem their notes on September 11, 2004.

LabCorp(R) Scheduled to Present at the Thomas Weisel Partners Health Care Conference

BURLINGTON, N.C., Sept. 8 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the Thomas Weisel Partners Health Care Conference in Boston, MA